AngioDynamics ANGO Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's accrued expenses?
- AngioDynamics (ANGO) reported accrued expenses of $4.66M in Q4 2025.
- How has AngioDynamics's accrued expenses changed year-over-year?
- AngioDynamics's accrued expenses decreased by 19.1% year-over-year, from $5.76M to $4.66M.
- What is the long-term trend for AngioDynamics's accrued expenses?
- Over 4 years (2021 to 2025), AngioDynamics's accrued expenses has grown at a 31.2% compound annual growth rate (CAGR), from $2.5M to $7.39M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.